A chronic, often progressive neurological disease, also known as MS, in which the immune system attacks the protective sheath around nerve fibers, causing walking difficulties, muscle weakness and spasticity, and fatigue.
LATEST ARTICLES
-
-
Getting Diagnosed with MS...
More than 2.3 million people around the world are affected by Multiple Sclerosis (MS), an autoimmune disease that damages the central nervous system. I am one of them.
-
A Decade of Innovation in Treatment for Multiple Sclerosis (MS) Patients
Ten years ago, treatments were limited to a handful of medicines. Today, MS patients have more treatment options with fewer side effects.
-
Multiple Sclerosis: Then and Now
While there is no cure for multiple sclerosis (MS), a decade of innovation has changed the way we treat the disease and enhance the lifestyles of people living with it.
RELATED ARTICLES
Tackling Neurological Disorders in New Ways
Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well-known and prevalent diseases afflicting the more than 100 million Americans who are impacted by a neurological disorder.
Tackling Neurological Disorders in New Ways
Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well-known and prevalent diseases afflicting the more than 100 million Americans who are impacted by a neurological disorder.
I'm Not Going to Let My MS Diagnosis Get to Me
Although most patients with multiple sclerosis (MS) are diagnosed between age 20 and 40, my story is a little different.
Researcher Profile: Ian Reynolds
Ian leads the Small Molecule Discovery Group at Teva Pharmaceuticals, where he is focused on drug discovery for neurological and neurogenerative diseases, such as Parkinson’s and multiple sclerosis (MS).
